Human medicines European public assessment report (EPAR): Vyepti, eptinezumab, Date of authorisation: 24/01/2022, Revision: 8, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 29 May 2026 - 13:52

Human medicines European public assessment report (EPAR): Vyepti, eptinezumab, Date of authorisation: 24/01/2022, Revision: 8, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/vyepti

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters